These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19318550)

  • 1. Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.
    Yuan JM; Koh WP; Murphy SE; Fan Y; Wang R; Carmella SG; Han S; Wickham K; Gao YT; Yu MC; Hecht SS
    Cancer Res; 2009 Apr; 69(7):2990-5. PubMed ID: 19318550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers.
    Yuan JM; Gao YT; Murphy SE; Carmella SG; Wang R; Zhong Y; Moy KA; Davis AB; Tao L; Chen M; Han S; Nelson HH; Yu MC; Hecht SS
    Cancer Res; 2011 Nov; 71(21):6749-57. PubMed ID: 22028322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
    Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
    Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
    Ter-Minassian M; Asomaning K; Zhao Y; Chen F; Su L; Carmella SG; Lin X; Hecht SS; Christiani DC
    Int J Cancer; 2012 Mar; 130(6):1338-46. PubMed ID: 21544809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer.
    Park SL; Carmella SG; Ming X; Vielguth E; Stram DO; Le Marchand L; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):561-9. PubMed ID: 25542827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
    Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
    Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco-specific N-nitrosamine exposures and cancer risk in the Shanghai Cohort Study: remarkable coherence with rat tumor sites.
    Stepanov I; Sebero E; Wang R; Gao YT; Hecht SS; Yuan JM
    Int J Cancer; 2014 May; 134(10):2278-83. PubMed ID: 24243522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers.
    Yuan JM; Knezevich AD; Wang R; Gao YT; Hecht SS; Stepanov I
    Carcinogenesis; 2011 Sep; 32(9):1366-71. PubMed ID: 21734256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
    Carmella SG; Akerkar SA; Richie JP; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
    Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
    Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.
    Vardavas CI; Fthenou E; Patelarou E; Bagkeris E; Murphy S; Hecht SS; Connolly GN; Chatzi L; Kogevinas M
    Tob Control; 2013 May; 22(3):194-200. PubMed ID: 22253001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.
    Hou H; Zhang X; Tian Y; Tang G; Liu Y; Hu Q
    J Pharm Biomed Anal; 2012 Apr; 63():17-22. PubMed ID: 22366322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
    Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.
    Bhat SH; Gelhaus SL; Mesaros C; Vachani A; Blair IA
    Rapid Commun Mass Spectrom; 2011 Jan; 25(1):115-21. PubMed ID: 21154658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers.
    Church TR; Anderson KE; Caporaso NE; Geisser MS; Le CT; Zhang Y; Benoit AR; Carmella SG; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):260-6. PubMed ID: 19124507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk.
    Chung CJ; Lee HL; Yang HY; Lin P; Pu YS; Shiue HS; Su CT; Hsueh YM
    Sci Total Environ; 2011 Apr; 409(9):1638-42. PubMed ID: 21334728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking.
    Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P; Benowitz NL
    Nicotine Tob Res; 2011 Mar; 13(3):202-8. PubMed ID: 21330276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.
    Vogel RI; Carmella SG; Stepanov I; Hatsukami DK; Hecht SS
    Biomarkers; 2011 Sep; 16(6):491-7. PubMed ID: 21812592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cruciferous vegetable consumption on urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in singapore chinese.
    Hecht SS; Carmella SG; Kenney PM; Low SH; Arakawa K; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):997-1004. PubMed ID: 15184256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.